Display Settings:

Items per page

Results: 1 to 20 of 400

1.
Figure 1

Figure 1. From: Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).

Proposed WHO-based nested classification of malignant lymphoid neoplasms. (A) Proposed WHO-based nested classification of malignant lymphoid neoplasms for epidemiologic research. (B) Proposed WHO-based nested classification of malignant lymphoid neoplasms: mature B-cell subtypes. (C) Proposed WHO-based nested classification of malignant lymphoid neoplasms: mature T-cell subtypes.

Lindsay M. Morton, et al. Blood. 2007 July 15;110(2):695-708.
2.
Figure 2.

Figure 2.Spatial clusters (hot spots) of the nine malignant neoplasms in Taiwan.. From: Spatial autocorrelation calculations of the nine malignant neoplasms in Taiwan in 2005-2009: a gender comparison study.

Maps show the spatial clusters of the nine malignant neoplasms in Taiwan: tracheal, bronchial, and lung cancer are designated by A; liver and intrahepatic bile duct cancer by B; colon and rectal cancer by C; stomach cancer is designated by D; oral cavity cancer by E; and esophageal cancer by F; pancreatic cancer is designated by G; non-Hodgkin's lymphoma by H; and leukemia by I. Gender is indicated by a number, where male is 1 and female is 2.

Pui-Jen Tsai. Chin J Cancer. 2011 November;30(11):757-765.
3.
Fig 2.

Fig 2. From: Second Malignant Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia.

Survival curves according to the four major categories of second malignant neoplasms (SMNs). Hemat, hematologic; CA, carcinoma.

Kjeld Schmiegelow, et al. J Clin Oncol. 2013 July 1;31(19):2469-2476.
4.
Figure 6

Figure 6. From: Evolving Patterns in the Detection and Outcomes of Pancreatic Neuroendocrine Neoplasms.

Comparison of survival rates among patients with pancreatic neuroendocrine neoplasms for benign and malignant neoplasms (A) as well as functional and nonfunctional neoplasms (B).

Parsia A. Vagefi, et al. Arch Surg. 2007 April;142(4):347-354.
5.
Fig 1.

Fig 1. From: Second Malignant Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia.

Kaplan-Meier estimates of the interval between diagnosis of acute lymphoblastic leukemia (ALL) and development of the four major categories of second malignant neoplasms.

Kjeld Schmiegelow, et al. J Clin Oncol. 2013 July 1;31(19):2469-2476.
6.
Figure 1

Figure 1. From: Years of life lost due to malignant neoplasms characterized by the highest mortality rate.

Trends of the number of years of life lost due to malignant neoplasms in total according to gender in the Lodz province from 1999 to 2008

Malgorzata Pikala, et al. Arch Med Sci. 2014 October 27;10(5):999-1006.
7.
Figure 2

Figure 2. From: Years of life lost due to malignant neoplasms characterized by the highest mortality rate.

Trends of the number of years of life lost in males due to common malignant neoplasms according to location in the Lodz province from 1999 to 2008

Malgorzata Pikala, et al. Arch Med Sci. 2014 October 27;10(5):999-1006.
8.
Figure 3

Figure 3. From: Years of life lost due to malignant neoplasms characterized by the highest mortality rate.

Trends of the number of years of life lost in females due to common malignant neoplasms according to location in the Lodz province from 1999 to 2008

Malgorzata Pikala, et al. Arch Med Sci. 2014 October 27;10(5):999-1006.
9.
Figure 3

Figure 3. From: Second Solid Malignancies among Children, Adolescents and Young Adults Diagnosed with Malignant Bone Tumors after 1976: Follow-up of a Children's Oncology Group Cohort.

Overall survival of 17 patients with solid second malignant neoplasms since their solid second malignant neoplasms date.

Robert Goldsby, et al. Cancer. ;113(9):2597-2604.
10.

Figure. From: ECM1 and TMPRSS4 Are Diagnostic Markers of Malignant Thyroid Neoplasms and Improve the Accuracy of Fine Needle Aspiration Biopsy.

FIGURE 1. Box plot of ECM1, TMPRSS4, and SELP mRNA expression in benign and malignant thyroid neoplasms. The values are normalized ECM1, TMPRSS4, and SELP mRNA expression to GUS mRNA expression. The box represents 50% of data (above 25% percentile and below 75% percentile) and the line within the box is the median value.

Electron Kebebew, et al. Ann Surg. 2005 September;242(3):353-363.
11.
Fig. 5

Fig. 5. From: Pancreatic cystic neoplasms: a review of preoperative diagnosis and management .

Malignant mucinous cystic neoplasms (MCNs) were found at the head of pancreas in a 77-year-old woman with obstructive jaundice and high carcinoembryonic antigen 19-9 level
Whipple’s procedure was done. (a) Whipple’s specimen; (b) Pancreatic head cystic lesion being malignant (see arrow)

Xue-li Bai, et al. J Zhejiang Univ Sci B. 2013 March;14(3):185-194.
12.
Figure 3

Figure 3. From: Contribution of dynamic sentinel lymphoscintigraphy images to the diagnosis of patients with malignant skin neoplasms in the upper and lower extremities.

Patterns of lymphatic drainage in cases of malignant skin neoplasms in the lower and upper extremities interpreted by mutual agreement. a) In cases of the lower extremities: 14 inguinal type (67%), one popliteal type (5%), and 6 inguinal and popliteal type (28%). b) In cases of the upper extremities: one axillary type (25%), one cubital type (25%), and 2 axillary and cubital type (50%).

Hiroyuki Miura, et al. Springerplus. 2014;3:625.
13.
Fig 1.

Fig 1. From: Occurrence of Multiple Subsequent Neoplasms in Long-Term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.

Survivors with multiple neoplasms after first subsequent neoplasm (SN) when SN1 is (A) nonmelanoma skin cancer (NMSC), (B) breast cancer, (C) meningioma, (D) thyroid cancer, (E) soft tissue sarcoma (STS), and (F) CNS malignancies (Malig). Gold, blue, and black boxes represent subsequent malignant neoplasms (SMNs), NMSCs, and benign neoplasms, respectively. NHL, non-Hodgkin's lymphoma.

Gregory T. Armstrong, et al. J Clin Oncol. 2011 August 1;29(22):3056-3064.
14.

Figure. From: Sequential Accumulation of K-ras Mutations and p53 Overexpression in the Progression of Pancreatic Mucinous Cystic Neoplasms to Malignancy.

Figure 1. Spectrum of lesions microdissected from mucinous cystic neoplasms. (A) Cyst epithelium without dysplasia. (B) Epithelium with mild dysplasia. (C) Epithelium with severe dysplasia. (D) Stromal invasion by malignant epithelial islands.

Ramon E. Jimenez, et al. Ann Surg. 1999 October;230(4):501-501.
15.

Figure. From: ECM1 and TMPRSS4 Are Diagnostic Markers of Malignant Thyroid Neoplasms and Improve the Accuracy of Fine Needle Aspiration Biopsy.

FIGURE 2. Receiver operating characteristic curve of normalized ECM1 and TMPRSS4 mRNA expression for distinguishing benign from malignant thyroid neoplasms. Combined use of both markers was more accurate than one marker alone. Area under the curve of 1.0 represents a “perfect” diagnostic test without any false-negative or false-positive results.

Electron Kebebew, et al. Ann Surg. 2005 September;242(3):353-363.
16.
Figure 2

Figure 2. From: Decision making for pancreatic resection in patients with intraductal papillary mucinous neoplasms.

The predictors of malignant intraductal papillary mucinous neoplasms. Receiver operating characteristic analysis showed that γ-GT > 50 U/L, alkaline phosphatase (ALP) > 115 U/L or carbohydrate antigen 19-9 (CA19-9) > 37 U/mL effectively predicted malignant intraductal papillary mucinous neoplasms. However, the area under the curve for CA19-9 > 37 U/mL was the largest among the three indices and reached 0.939 (P < 0.01, 95%CI: 0.843-1.035).

Bin Xu, et al. World J Gastroenterol. 2013 March 7;19(9):1451-1457.
17.
Figure 1

Figure 1. From: Tumor Resection Cavity Administered Iodine-131-Labeled Anti-tenascin 81C6 Radioimmunotherapy in Patients with Malignant Glioma: Neuropathology Aspects.

Tumor recurrence in these active malignant neoplasms was characterized by dense hypercellularity associated with nuclear pleomorphism and vascular proliferation. Although areas of necrosis were easily found, the influence of therapeutic effect was not often readily discernible; thus, these recurrences were characterized as “active malignant gliomas” (H&E; 250×).

Roger E. McLendon, et al. Nucl Med Biol. ;34(4):405-413.
18.
Figure 4.

Figure 4.Microscopic featuies of malignancy of mucinuous cystic neoplasms.. From: Pancreatic pseudocyst or a cystic tumor of the pancreas?.

A, the wall of the mucinous cystadenocarcinoma from the first patient shows microscopic foci of invasion by malignant epithelial cells (yellow arrows). This separates it from other types of mucinous neoplasms: the benign, the borderline, and the in situ cancer variants (HE, 10×); B, invasion of stroma is stained brown in malignant epithelial cell groups (immunohistochemistry, cytokeratin MNF116 antibody, 10×)

Mohammad Ezzedien Rabie, et al. Chin J Cancer. 2014 February;33(2):87-95.
19.
Fig 1.

Fig 1. From: Second Neoplasms in Survivors of Childhood Cancer: Findings From the Childhood Cancer Survivor Study Cohort.

Cumulative incidence of second malignant neoplasms (SMNs) and nonmelanoma skin cancer (NMSC) in childhood cancer survivors. At the 30-year follow-up, the cumulative incidence of SMNs and NMSC continues to increase with time since 5 years after diagnosis of primary childhood cancer.

Anna T. Meadows, et al. J Clin Oncol. 2009 May 10;27(14):2356-2362.
20.
Fig. 2

Fig. 2. From: Vaccination coverage in adults undergoing splenectomy: evaluation of hospital vaccination policies.

Percentage distribution of vaccinations with respect to vaccination before, during or after admission for splenectomy for each aetiological group. HaemD, Non-neoplastic haematological disease; MHN, malignant haematological neoplasms; MSON, malignant solid organ neoplasms; IS, incidental splenectomy.

L. BRUNI, et al. Epidemiol Infect. 2006 August;134(4):837-844.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk